Skip to main content
ABT logo
ABT
(NYSE)
Abbott Laboratories
$102.30-- (--)
Loading... - Market loading

Abbott Laboratories (ABT) Stock Price & Financial Analysis

Abbott Laboratories Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$101.45 - $102.87
52-Week High$139.06
52-Week Low$100.88
Open$101.83
Volume12.21M
Average Volume (3M)6.98M
Market Cap178.72B
Shares Outstanding1.75B
P/E Ratio (TTM)27.42
Forward P/E54.83
Price to Sales (P/S)4.03
Price to Book (P/B)3.43
EV/EBITDA15.95
Revenue (TTM)44.33B
Net Income (TTM)6.52B
Free Cash Flow (TTM)7.39B
EPS (TTM)$3.73
Profit Margin14.72%
Operating Margin18.17%
Return on Equity (ROE)12.51%
Debt to Equity0.29
50-Day MA$109.84
200-Day MA$124.45
52-Week Change-22.26%
Annual Dividend$2.40
Dividend Yield2.34%
Payout Ratio64.27%
Last Dividend Ex-DateApr 15, 2026

Frequently Asked Questions About Abbott Laboratories

What is the current stock price for ABT?

As of the latest trading session, ABT stock trades at $101.83. The 52-week range is $100.88–$139.06, with a day range of $101.45–$102.86.

What is the P/E ratio for ABT?

Abbott Laboratories's trailing P/E ratio is 27.4, meaning investors pay $27.4 for every $1 of annual earnings. The forward P/E is 54.8, reflecting analyst expectations for future earnings. Abbott Laboratories operates in the Healthcare sector.

Does ABT pay dividends?

Yes, Abbott Laboratories pays a 2.34% annual dividend yield ($2.40 per share). The payout ratio is 64.3%. The last ex-dividend date was 2026-04-15.

What do analysts recommend for ABT?

Based on 23 analysts, the consensus for ABT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ABT?

Abbott Laboratories's market capitalization is $177.90B, classifying it as a large-cap company. Abbott Laboratories operates in the Healthcare sector within the Medical Devices industry.